Wednesday 14 October 2026
Export MOH’s income statement to Excel — free account
Molina Healthcare, Inc
MOH Healthcare Healthcare Plans
Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024. In the quarter to June 2026, revenue fell 4.84%, EPS fell 75.0%, free cash flow grew 5.81% and total debt rose 10.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
209.87
5.51
+2.70%
Follow MOH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 39.44 | 20.27 | 11.85 |
+8 more quarters Free account |
P/S ratio |
0.26 | 0.15 | 0.20 | 0.23 | |
P/FCF ratio |
43.12 | 27.03 | 0.00 | 0.00 | |
P/Operating CF |
(39.75) | 6.27 | (30.75) | (80.37) | |
P/B ratio |
2.80 | 1.66 | 2.25 | 2.40 | |
Price to Tangible BV |
5.59 | 3.41 | 4.89 | 5.05 | |
EV/Sales |
0.15 | 0.03 | 0.11 | 0.12 | |
EV/EBITDA |
18.20 | 2.44 | 5.00 | 3.60 | |
EV/Operating CF |
18.49 | 4.22 | (9.13) | (11.88) | |
EV/FCF |
24.91 | 6.00 | (7.68) | (9.54) | |
Quick Ratio |
1.61 | 1.55 | 1.60 | 1.60 | |
Current Ratio |
1.68 | 1.63 | 1.69 | 1.68 | |
Net Debt/EBITDA |
(26.82) | (43.48) | 36.49 | (25.25) | |
Debt/Assets |
24.70% | 24.08% | 25.38% | 24.54% | |
Debt/Equity |
0.95 | 0.97 | 0.97 | 0.92 | |
Asset Turnover |
2.76 | 2.75 | 2.91 | 2.83 | |
Operating CF/Net income |
(4.90) | 77.29 | 1.86 | (1.58) | |
Capex/Depreciation |
(0.75) | (0.69) | 0.02 | (0.84) | |
Interest Coverage |
2.69 | 1.54 | (3.12) | 2.80 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.66% | 7.22% | 6.99% | 6.35% | |
Intangible Assets out of Total Assets |
0.13 | 0.13 | 0.14 | 0.14 | |
Share Based Compensation of Revenue |
0.24% | 0.31% | 0.18% | (0.03%) | |
Graham Net Nets |
0.09 | 0.15 | 0.10 | 0.10 | |
Graham Number |
0.00 | 78.08 | 121.83 | 170.32 | |
Earnings Yield |
(0.08%) | 2.54% | 4.93% | 8.44% | |
Free Cash Flow Yield |
2.32% | 3.70% | (6.94%) | (5.71%) | |
Revenue per Share |
212.80 | 212.10 | 215.44 | 218.61 | |
Operating CF per Share |
(5.75) | 21.26 | (5.64) | (2.38) | |
Capex per Share |
(0.59) | (0.53) | 0.02 | (0.72) | |
Free Cash Flow per Share |
(6.34) | 20.73 | (5.62) | (3.10) | |
Cash per Share |
174.46 | 181.75 | 156.36 | 160.90 | |
Shareholders Equity per Share |
81.62 | 80.16 | 77.06 | 79.83 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
81.62 | 80.16 | 77.06 | 79.83 | |
Free Cash Flow |
(324.00) | 1,055.00 | (297.00) | (163.00) | |
Working Capital |
5,228.00 | 5,138.00 | 5,072.00 | 5,071.00 | |
Capital Expenditures |
(30.00) | (27.00) | 1.00 | (38.00) | |
Net Current Asset Value |
1,096.00 | 1,015.00 | 949.00 | 1,045.00 | |
EV/EBIT |
33.25 | 3.50 | 6.25 | 4.14 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
57.57 | 15.74 | 11.73 | 7.59 | |
| Other line items | |||||
Average Receivables |
3,675.00 | 3,455.50 | 3,416.00 | 3,387.00 | |
Average Payables |
1,126.00 | 1,140.00 | 1,212.00 | 1,169.50 | |
Average Assets |
16,106.00 | 16,388.50 | 15,597.00 | 15,728.00 | |
Average Common Equity |
4,387.00 | 4,195.00 | 4,282.50 | 4,480.50 |
Columns are period end dates